Related Experiment Video
Updated: Feb 4, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Anticancer Agent-Induced Life-Threatening Skin Toxicities: A Database Study of Spontaneous Reporting Data
Ryota Tanaka1,2,3, Kan Yonemori4, Akihiro Hirakawa5
1Divisions of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Abstract:
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are potentially life-threatening cutaneous and mucosal adverse reactions to drugs. Nevertheless, the connection to anticancer agents remains unclear. To provide insight into the association of such adverse reactions with anticancer agents, we analyzed the profile of anticancer agent-induced SJS and TEN in the Japanese population. Of the 9,738 SJS/TEN events recorded in a database of spontaneous reporting data, 485 (5%, further categorized as SJS, 384 events, 79%; TEN, 101 events, 21%) were identified as anticancer agent-induced, and 53 of these (11%) were fatal. Multivariate logistic regression analyses indicated that, compared with patients using other drugs, those using anticancer drugs had lower incident risk of death (hazard ratio [HR], 0.592; p = .0006), longer median time to onset of SJS/TEN (18 vs. 11 days; p < .0001; multivariate Cox regression: HR, 0.66; p < .0001), and a higher likelihood of developing SJS/TEN later than 70 days after initiation of the suspected causal agent (15% vs. 7%; p < .0001), highlighting the need for vigilance and continuous monitoring for SJS/TEN in patients treated with anticancer agents. IMPLICATIONS FOR PRACTICE: Life-threatening skin toxicities induced by anti-cancer agents indicated significantly lower incident risk of death and longer time to onset of symptoms than for those induced by other drugs.
Insights
Anticancer drugs are linked to Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), but with a lower death risk and longer onset time than other drugs. Continuous monitoring is crucial for patients on anticancer agents.
Area of Science:
- Pharmacovigilance
- Dermatology
- Oncology
Background:
- Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe adverse drug reactions affecting skin and mucous membranes.
- The association between anticancer agents and SJS/TEN is not fully understood, necessitating further investigation.
Purpose of the Study:
- To analyze the characteristics and outcomes of SJS/TEN cases induced by anticancer agents in the Japanese population.
- To compare the risk of mortality, time to onset, and delayed onset of SJS/TEN between anticancer drugs and other medications.
Main Methods:
- Analysis of a spontaneous reporting database containing 9,738 SJS/TEN events.
- Identification of 485 events (5%) attributed to anticancer agents.
- Application of multivariate logistic and Cox regression analyses to compare outcomes.
Main Results:
- Anticancer agent-induced SJS/TEN accounted for 5% of all cases, with an 11% fatality rate.
- Patients on anticancer drugs had a significantly lower risk of death (HR=0.592) and a longer median time to SJS/TEN onset (18 vs. 11 days).
- A higher proportion of anticancer drug-related SJS/TEN cases (15%) occurred later than 70 days after drug initiation compared to other drugs (7%).
Conclusions:
- Anticancer agents are associated with SJS/TEN, but these reactions appear to have a better prognosis regarding mortality and onset timing compared to those induced by other drugs.
- Vigilance and continuous monitoring for SJS/TEN are essential for patients undergoing anticancer therapy due to the potential for delayed onset.
More Related Videos
Related Concept Videos
Data Reporting and Recording
Spontaneous and Induced Mutations
Spontaneity
Half-life of a Reaction
Characteristics of Life
The Angiosperm Life Cycle

